Daily Journal Staff Writer
Class and mass action lawyers for both the plaintiff and defense had better be careful what they seek.
That was the lesson of Monday's announcement from the 9th U.S. Circuit Court of Appeals that it has voted to rehear en banc a September ruling by a three-judge panel returning to state court a potential mass action over the pain drug propoxyphene, sold under Darvon and other brand names.
...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In